Company news
Level Bio AB news in 2025
Level Bio AB's news releases, calls and decks from 2025, newest first.
LEVBIO: Q3 2025 saw 5% revenue growth, higher margins, and improved cash flow amid Nordic expansion
October 23, 2025
LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development
August 21, 2025
LEVBIO: Nordic market growth surged 44% year-over-year, fueled by rebranding and tech advances
April 24, 2025
LEVBIO: Improved margins and reduced losses signal a turnaround, but liquidity remains a key risk
February 20, 2025